NEW YORK (GenomeWeb News) – Tecan said today that it will collaborate with Innovatis to jointly market robotic cell culture workstations and cell detection devices.

Under the agreement, the companies will co-market Innovatis' Cellavista automated image-based cellular analysis platform and Tecan's Freedom EVO platform. Used together, Tecan said, the platforms allow automation of a wide range of cell-related processes including cell line development, cell proliferation, stem cell differentiation, and cell-based assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.